Don Beeman

Donald Beeman is the former Chief Executive Officer of LigoCyte Pharmaceuticals, Inc., in Bozeman, Montana. Mr. Beeman led LigoCyte through fundraising, the development of several preclinical candidates and moved the company’s norovirus research program into the clinic. The company was acquired by Takeda in October 2012. He was a Founder and served as the Director at Topaz Pharmaceuticals LLC. Topaz was acquired by Sanofi Pasteur.

Prior to that, Mr. Beeman served as Vice President at Merck & Co., Inc. (1989-2004), where he led commercial operations for the vaccine business in the United States, reporting to the division head. He guided the creation of Merck’s first e-business channel with physicians and led two different regional sales groups at Merck, helping to establish five new products during his tenure in this role in the company’s pharmaceutical division. Mr. Beeman has held several different marketing positions including assignments in product marketing, customer marketing, and as the Marketing Director in the Australian subsidiary of Merck.